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Abstract
Background: Culture shapes how people understand illness and death, but few studies examine whether acculturation
influences patients’ end-of-life treatment preferences and medical care.
Methods and Findings: In this multi-site, prospective, longitudinal cohort study of terminally-ill cancer patients and their
caregivers (n=171 dyads), trained interviewers administered the United States Acculturation Scale (USAS). The USAS is a 19-
item scale developed to assess the degree of ‘‘Americanization’’ in first generation or non-US born caregivers of terminally-ill
cancer patients. We evaluated the internal consistency, concurrent, criterion, and content validity of the USAS. We also
examined whether caregivers’ USAS scores predicted patients’ communication, treatment preferences, and end-of-life
medical care in multivariable models that corrected for significant confounding influences (e.g. education, country of origin,
English proficiency). The USAS measure was internally consistent (Cronbach a=0.98); and significantly associated with US
birthplace (r=0.66, P,0.0001). USAS scores were predictive of patients’ preferences for prognostic information (AOR=1.31,
95% CI:1.00–1.72), but not comfort asking physicians’ questions about care (AOR 1.23, 95% CI:0.87–1.73). They predicted
patients’ preferences for feeding tubes (AOR=0.68, 95% CI:0.49–0.99) and wish to avoid dying in an intensive care unit
(AOR=1.36, 95% CI:1.05–1.76). Scores indicating greater acculturation were also associated with increased odds of patient
participation in clinical trials (AOR=2.20, 95% CI:1.28–3.78), compared with lower USAS scores, and greater odds of patients
receiving chemotherapy (AOR=1.59, 95% CI:1.20–2.12).
Conclusion: The USAS is a reliable and valid measure of ‘‘Americanization’’ associated with advanced cancer patients’ end-
of-life preferences and care. USAS scores indicating greater caregiver acculturation were associated with increased odds of
patient participation in cancer treatment (chemotherapy, clinical trials) compared with lower scores. Future studies should
examine the effects of acculturation on end-of-life care to identify patient and provider factors that explain these effects and
targets for future interventions to improve care (e.g., by designing more culturally-competent health education materials).
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Introduction
The provision of culturally sensitive medical care is likely to
become an increasingly important issue as the Health Care
Reform Act extends access to over 30 million previously uninsured
Americans, many of whom will be immigrants. In 2010, 36% of
the United States (US) population identified as racial or ethnic
minorities, [1] and nearly 13% were foreign-born. [2] As the US
becomes increasingly diverse, there is a growing need to
understand how patients’ cultural beliefs and perspectives may
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Oinform their medical decision-making. Given that minorities tend
to be diagnosed with cancer at more advanced stages compared
with white patients,[3–7] there is a particular need to understand
how acculturation affects medical decision-making in late-stage
disease. This information is crucial for the provision of culturally-
competent health education, informed medical decision-making,
and the delivery of effective and equitable medical care.
In the US, racial and ethnic minorities receive fewer definitive
cancer treatments and have lower five-year survival rates,[7–13]
but receive more aggressive end-of-life care.[14–17] Healthcare
disparities may be heightened in immigrants due to language
barriers,[18–24] reduced access to care,[25–27] and/or different
cultural values. [28,29] Research has documented variations in
treatment preferences and advance care planning among racial
and ethnic minority groups.[30–32] To date, few studies have
examined whether US acculturation influences cancer patients’
communication with physicians, treatment preferences, or medical
care among first-generation and non-US born patients. To the
extent that acculturation influences medical decision-making and
care, it might help inform interventions to reduce ethnic disparities
(e.g., by providing health information that is tailored to patients’
degree of US acculturation to ensure that patients are making well-
informed decisions that are consistent with their cultural values
and beliefs).
Acculturation describes a process by which the behaviors,
values, beliefs, and identity of individuals from one culture are
modified as a result of contact with another culture. [33,34]
Previous studies have found that higher US acculturation levels are
associated with increased cancer screening, [4] receipt of
recommended cancer therapies, [35] and advance care planning.
[36] One major limitation of existing studies, however, is that most
rely upon proxy measures of US acculturation (e.g., language,
foreign birthplace) that cannot capture the range of behaviors,
preferences, identity, values, and social interactions associated with
acculturation. Although several unidimensional and bidimensional
acculturation scales have been developed,[37–40] each has
limitations, including an over-reliance upon language, validation
within a single ethnic group, or the inclusion of sociodemographic
characteristics as proxy measures. [34].
This report describes the development and validation of a new
acculturation scale, the ‘‘United States Acculturation Scale: A
Measure to Assess Americanization’’ (USAS). The primary aim of
this study was to determine the reliability and validity of this scale,
which was administered to caregivers of terminally-ill cancer
patients, rather than patients, to minimize burden on dying
patients. The secondary aim was to examine associations between
caregivers’ US acculturation levels and advanced cancer patients’
communication with physicians, treatment preferences, advance
care planning, and cancer treatment received (i.e. chemotherapy,
clinical trials, or symptom management).
We hypothesized that patients with more ‘‘Americanized’’
caregivers would have stronger preferences for prognostic
information because they would feel better able to understand
and use this information and because prognostic disclosure is more
common in the US than other countries.[41–44] We also
hypothesized that patients with more acculturated caregivers
would be less likely to want intensive life-prolonging care at the
end-of-life, [43] compared with patients whose caregivers were less
acculturated. We expected more ‘‘Americanized’’ caregivers might
have past experiences with intensive medical care that might
enable them to evaluate better the risks and benefits of this
intensive care at the end-of-life. [45] Less Americanized caregivers
were expected to have values consistent with more religious and
less educated ethnic minority patients whom we have shown to
prefer more intensive end-of-life care. [46,47].
Methods and Findings
Ethics
The institutional review boards of the Dana-Farber/Partners
Cancer Center, Yale University, Parkland Hospital, West Haven
Veterans’ Affairs Connecticut Comprehensive Cancer Center
Clinic, Parkland Hospital, Simmons Comprehensive Cancer
Center, and New Hampshire Oncology-Hematology approved
all study procedures.
Study Sample
Our data were collected as part of the Coping with Cancer
study, a National Cancer Institute and National Institute of
Mental Health-funded prospective, multi-institution cohort study
of terminally ill cancer patients and their unpaid, informal
caregivers (e.g., spouse, adult child). Participants were recruited
from September 2002 to February 2008 from three academic
institutions, a Veterans’ Administration hospital, ‘‘safety-net’’
center that serves many non-native citizens, and a private practice:
Yale Cancer Center (New Haven, Connecticut), Simmons
Comprehensive Cancer Center (Dallas, Texas), Dana-Farber/
Partners Cancer Center (Boston, Massachusetts), the West Haven
Veterans’ Affairs Connecticut Comprehensive Cancer Center
Clinic (West Haven, Connecticut), Parkland Hospital (Dallas,
Texas), and New Hampshire Oncology-Hematology (Hooksett
and Londonderry, New Hampshire).
Eligibility criteria included: diagnosis of advanced cancer
(distant metastases and disease refractory to first-line chemother-
apy); age $20 years; presence of an informal caregiver; and clinic
staff/interviewer assessment that the patient had adequate stamina
to complete the interview. Patient-caregiver dyads in which either
the patient or caregiver refused to participate, met criteria for
dementia or delirium (by neurocognitive status examination), or
did not speak either English or Spanish were excluded. All study
participants provided written informed consent and were given a
choice to be interviewed in English or Spanish. Interviews were
conducted in English or Spanish by bilingual interviewers who
were trained by the bilingual and bi-cultural scale developers.
Each interviewer was required to meet study standards (e.g.,
.80% agreement between the scale developers and the trainee on
the rating of how acculturated/‘‘Americanized’’ the caregiver was)
before being permitted to collect data for the study. Patients were
followed from enrollment to death, and the caregivers were
followed to a final study assessment of approximately 6 months
after the death.
Of the 917 eligible participants, 638 patient-caregiver dyads
(69.6%) consented and enrolled in the larger study. Of the 279
patients who refused participation, 120 were not interested, 69
cited other reasons, and 37 had caregivers who refused. There
were no differences in the sociodemographic characteristics
between participants and non-participants, except participants
were more likely to be Hispanic (11.8% vs. 5.7%, p=0.006). For
the present analysis we restricted our sample to the 171 patient-
caregiver dyads in which both identified as either non-US-born or
first generation American, and the caregiver completed the
acculturation scale. This group did not differ significantly
(p,0.05) from the larger sample by gender, cancer type,
performance status, or caregiver relationship (e.g. spouse, adult
child). However, as expected, non-US-born and first generation
Americans were more likely to have characteristics associated with
recent immigration (e.g., be younger, non-native English speakers,
US Acculturation and End-of-Life Cancer Care
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Hispanic). The USAS was administered to caregivers of terminal-
ly-ill cancer patients as a proxy for patients’ degree of accultur-
ation in order to minimize participant burden in this sample of
dying patients.
Measures
The United States Acculturation Scale. The USAS scale
(Table S1) was developed from a literature review and the authors’
experiences caring for cancer patients at Parkland Hospital, a
‘‘safety-net’’ center that serves many non-native citizens, over the
past decade. It was also informed by two of the scale’s developers’
(HS, YMK) experiences as dual citizens of the US and Mexico.
The USAS scale assesses the degree of acculturation to American
life with 19 items that measure language preferences and
proficiency and cultural identity (e.g., music, entertainment, and
food preferences; contact with English-language mass media;
friendships, social interactions with US-born residents compared
with others, frequency of contact with country of origin, and burial
site preferences). The scale differentiates between five levels of
acculturation–(1) Non-American only, (2) mostly non-American,
(3) bicultural, (4) mostly American, and (5) American only–
measured on a five-point Likert scale with higher scores reflecting
greater ‘‘Americanization.’’ Scores on each scale item were totaled
and divided by the number of items. In addition, the scale
included the trained bilingual interviewer’s assessment of the
respondent’s degree of acculturation, rated on a five-point Likert
scale from ‘‘Completely non-American’’ to ‘‘Completely Ameri-
canized.’’
US acculturation was measured in caregivers instead of patients
to limit subject burden because our population of interest consisted
of terminally-ill cancer patients. Although acculturation levels may
differ between patients and caregivers, caregiver participants were
identified by patients as ‘‘the person who provides you with the
most unpaid assistance with your activities of daily living; e.g.
bathing, cooking, transportation, housework, etc.’’ As such, we
expected that enrolled caregivers would be the people whom
patients depended upon most, and therefore would likely be
influential participants in patients’ medical decision-making.
Patient acculturation was assessed with the five item Cuellar’s
validated ‘‘Acculturation Rating Scale for Mexican Americans’’
(ARS) short-form, [33] to minimize respondent burden in
terminally ill patients. The five items, selected from the 20-item
ARS, measured participants’ language preferences (e.g., in speech,
writing, and thought) and language(s) spoken at home and with
friends during childhood and now. Items were coded on a five-
point Likert scale which ranged from ‘‘only non-English’’ to ‘‘only
English,’’ with higher scores reflecting a stronger English
language/Anglo orientation.
Sociodemographic characteristics. Participants’ age, gen-
der, race/ethnicity, marital status, education, health insurance,
and religious affiliation were recorded as reported. Race or
ethnicity was determined by patient self-report in response to the
open-ended question: ‘‘What race or ethnicity do you consider
yourself to be?’’ Patients who identified as Hispanic were analyzed
as such, regardless of race. Patients were specifically asked for their
birthplace and native language. Caregivers provided similar
sociodemographic information and their kinship relationship to
the patient (e.g. spouse, adult child).
Disease characteristics and health status. Research staff
reviewed the medical record and verified each patient’s primary
cancer, stage, and performance status with the treating physician.
Patients’ performance status and co-morbid medical conditions
were assessed with the Karnofsky score and Charlson Comorbidity
Index, respectively. [48,49] Patients’ symptom burden was
measured with the McGill Quality of Life Index’s physical health
subscale. [50].
Patient-Physician communication. Because previous stud-
ies have documented differences in physicians’ affective and
instrumental communication with ethnic minorities compared
with white patients, [51] we sought to determine whether
communication processes differed by acculturation level. Patients
were asked in yes/no questions if they trusted their physician,
whether doctors treated them with respect, and whether they had
discussed their wishes for the type of care they would want to
receive if dying with their physician. Patients were also asked:
‘‘How comfortable are you asking your doctor questions about
your care?’’ using a five-point Likert scale (very uncomfortable to
very comfortable).
Treatment preferences and planning. In the baseline
interview patients were asked, ‘‘If your physician knew how long
you had left to live, would you want him or her to tell you?’’ and
‘‘Would you want to be kept alive if it required being on a feeding
tube?’’ Patients were also asked: ‘‘Do you think it would be a bad
thing for a person to die in the ICU versus elsewhere (e.g., home,
hospital, or hospice).’’Response options were ‘‘yes’’ or ‘‘no.’’
Finally, patients were asked, ‘‘If you could choose, would you
prefer: 1) a course of treatment that focused on extending life as
much as possible, even if it meant more pain and discomfort, or 2)
a plan of care that focused on relieving pain and discomfort as
much as possible, even if that meant not living as long?’’ Response
options were ‘‘extend life as much as possible,’’ ‘‘relieve pain or
discomfort as much as possible,’’ or ‘‘don’t know.’’
Treatments. Active treatments (palliative chemotherapy,
radiation, pain management, and participation in clinical trials)
were abstracted from the medical record and verified with the
treating oncologist.
Statistical Analyses
Cronbach’s a was used to evaluate the scale’s internal
consistency (reliability) and to identify items that, if removed,
would improve it. Principal component analyses produced item-
factor loadings and eigenvalues for emergent factors. t tests and
analysis of variance were used, depending upon whether the
outcome was continuous or categorical, to examine associations
between patients’ sociodemographic and health characteristics and
caregivers’ acculturation level (e.g., caregivers’ mean USAS for
patients who had health insurance, compared with those who did
not).
Pearson correlation coefficients were used to estimate relation-
ships between the scale and patients’ birthplace (United States vs.
other), native language (English vs. other); and language
proficiency (choice of English vs. Spanish for interview) as a
measure of the scale’s concurrent validity. Criterion/construct
validity was assessed by examining correlations between the
caregivers’ USAS scale scores and: 1) patients’ scores on Cuellar’s
validated ARS and 2) the rater’s perception of caregivers’
acculturation. A linear regression model estimated the unique
contributions of the language and cultural identity items on the
rater’s perception of caregivers’ acculturation level.
To assess predictive validity, multivariable regression models
estimated the effects of caregivers’ acculturation on patient-
physician communication, treatment preferences, and cancer
treatment at baseline, a median of 5.8 months before death.
Every variable that was associated (p,0.20) with both the
predictor (caregiver acculturation) and outcome (e.g. treatment)
was investigated as a potential confound and retained if significant
US Acculturation and End-of-Life Cancer Care
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(version 9.2; SAS Institute, Inc, Cary, NC).
Results
Table 1 shows that the USAS had a high degree of internal
consistency (Cronbach’s a=0.98). All questions had high item-
total correlations, except for contact with country of origin
(r=0.27), which was retained because it captured a unique
behavioral measure of acculturation and did not compromise the
scale’s overall internal consistency. A principal components
analysis of the 19-item USAS revealed a single emergent factor
(eigenvalue=14.22) that accounted for 79.0% of the variance in
the data; a review of the scree plot further confirmed the presence
of a single factor (data not shown).
As shown in Table 2, patients whose caregivers had scores
indicating lower acculturation levels were more likely to identify as
Hispanic and Catholic, have fewer years of formal education, be
uninsured, have been born outside of the US, and have lower
Karnofsky scores, compared with patients with more acculturated
caregivers. There were also significant differences in acculturation
levels by institution; e.g., caregivers’ USAS scores were signifi-
cantly lower at Parkland Hospital and Simmons Comprehensive
Cancer Center, compared with the Yale Cancer Center.
Caregivers were highly involved in patients’ care; 62% reported
providing more than 80% of patients’ informal care. There were
no differences in the type of relationships between patients and
caregivers, or the extent of informal care provided by accultur-
ation status.
Caregivers’ USAS language and cultural identity scores were
closely and highly statistically significantly associated with patients’
birthplace, native language, and English proficiency, as shown in
Table 3. They were also closely associated with patients’ scores on
the Cuellar Brief Acculturation Scale (r=0.65 and r=0.60,
p,0.0001, respectively), although 46.6% of cancer patients did
not complete this measure, which validated our concern about
administering the USAS to terminally ill patients. Caregivers’
English proficiency was also closely associated with their USAS
scores (r=0.86, p,0.0001 for full scale), and the raters’ assessment
of caregivers’ degree of acculturation (r=0.86, p,0.0001 for the
full scale).
Table 4 shows that items measuring caregivers’ language and
cultural identities were independently and highly statistically
significantly associated with raters’ assessments of caregivers’
acculturation level. These results suggest that USAS’ items
measuring caregivers’ cultural identity were distinct from those
that measured caregivers’ language preferences and proficiency,
and that each uniquely contributed to independent raters’
assessment of caregivers’ level of US acculturation.
As shown in Table 4, patients whose caregivers had scores
indicating lower acculturation levels were more likely to identify
as Hispanic and Catholic, have fewer years of formal education,
Table 1. United States acculturation scale.
Correlation Analyses
Scale Items Item with Total
Item with Rater
Assessment
a Cronbach’s a 0.98
Language
What language do you speak most often?
1 0.95 0.90
What language do you prefer speaking?
1 0.95 0.90
What language do most of your friends speak?
1 0.93 0.87
You are most comfortable reading (newspapers, books, magazines) in
1 0.94 0.88
You are most comfortable writing in
1 0.94 0.89
You think most often in
1 0.94 0.88
Cultural Identity
The music you listen to most is in
1 0.90 0.84
The music you enjoy most is in
1 0.91 0.82
The TV shows you watch most are in
1 0.90 0.83
The TV shows you prefer watching most are in
1 0.92 0.86
The movies you watch most are in
1 0.88 0.82
Your father’s cultural identity was/is (country of origin)
2 0.58 0.58
Your mother’s cultural identity was or is (country of origin)
2 0.72 0.70
Your friends while you were growing up were of ______origin
2 0.81 0.75
Your family cooks/eats foods that are of _______ origin
2 0.82 0.74
Your friends now are of _______ origin
2 0.88 0.79
You like to identify yourself as
2 0.87 0.83
Where would you want to be buried?
3 0.61 0.67
Your contact (letters, phone calls, emails) with country of origin has been
4 0.27 0.23
aDependent variable was the interviewer’s evaluation of how ‘‘Americanized’’ the respondent was. Response options included Likert scales (scored 1–5):
1Non-English only to English only;
2Non-American to American;
3(Non-United States) country of origin vs. United States; and
4.twice/yr, .4 times/yr, monthly, weekly, or daily.
doi:10.1371/journal.pone.0058663.t001
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Full Sample Caregiver USAS
Patient Characteristics
a N (%) Mean (SD) P-value
Male 85 (52.2) 3.5 (1.5) 0.62
Age, years 0.12
,50 47 (27.5) 3.2 (1.6)
50–64 62 (36.3) 3.6 (1.4)
.65 54 (31.6) 3.8 (1.2)
Race/ethnicity ,0.0001
White 79 (48.5) 4.5 (0.7)
Black 8 (4.9) 4.7 (0.4)
Hispanic 70 (42.9) 2.3 (1.1)
Other 6 (3.7) 3.8 (0.7)
Married 116 (72.5) 3.6 (1.4) 0.99
Education, years ,0.0001
,8 53 (32.5) 2.4 (1.2)
8–12 39 (23.9) 4.0 (1.3)
.12 71 (43.6) 4.1 (1.0)
Health insurance ,0.0001
Insured 103 (63.2) 4.3 (0.9)
Uninsured 60 (35.1) 2.3 (1.1)
Native language
b ,0.0001
English 95 (55.6) 4.4 (0.8)
Non-English 68 (40.0) 2.4 (1.2)
Nativity ,0.0001
US-born 96 (56.1) 4.3 (0.9)
Foreign-born 67 (39.2) 2.4 (1.3)
Mexico 42 (24.6) 1.9 (0.9)
Central/South America 10 (5.9) 2.1 (1.0)
Europe 9 (5.3) 4.1 (1.0)
South/SouthEast Asia 4 (2.3) 3.5 (0.6)
Other 2 (1.2) 4.4 (0.7)
Cancer type 0.08
Breast 15 (8.8) 3.5 (1.3)
Gastrointestinal 60 (35.1) 3.5 (1.4)
Lung 27 (15.8) 4.1 (1.2)
Other
c 59 (34.5) 3.3 (1.5)
Full Sample Caregiver USAS
a
Patient Characteristics N (%) Mean (SD) P-value
Karnofsky
d 0.0004
.70 94 (55.0) 3.9 (1.3)
,70 66 (38.6) 3.1 (1.5)
Religion 0.0005
Catholic 90 (52.6) 3.2 (1.4)
Protestant 24 (14.0) 4.5 (0.8)
Other 41 (23.9) 3.6 (1.3)
None 8 (4.7) 4.2 (0.9)
Institution ,0.0001
Yale 62 (36.3) 4.4 (1.0)
VA 5 (2.9) 4.9 (0.1)
Simmons 6 (3.5) 3.1 (0.6)
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lower Karnofsky scores, compared with patients with more
acculturated caregivers. There were also significant differences
in acculturation levels by institution; e.g., caregivers’ USAS
scores were significantly lower at Parkland Hospital and
Simmons Comprehensive Cancer Center, compared with the
Yale Cancer Center.
As shown in Table 5, every unit increase in the caregiver’s
USAS score was associated with a 1.3 fold increase in the cancer
patient’s likelihood of wanting prognostic information
(AOR=1.31, 95% CI 1.00–1.72) and higher odds of wanting to
avoid dying in an ICU (OR=1.36, 95% CI 1.05–1.76). Higher
USAS scores were also associated with decreased odds of wanting
a feeding tube to extend life (AOR=0.68, 95% CI 0.49–0.99). We
did not detect any associations between caregivers’ acculturation
and measures of patients’ trust in physicians, comfort asking
questions about their care, or communication processes after
adjustment for other confounds.
Associations between advanced cancer patients medical care
and caregivers’ acculturation are shown in Table 6. For every unit
increase in the caregiver’s USAS score, the patient’s odds of
participating in clinical trials doubled (OR=2.20, 95% CI 1.28–
3.78). We investigated possible confounding influences, including
native English language, educational level, patient performance
status, and institution on the association between acculturation
and trial participation, but did not find any evidence of
confounding. Similarly, patients’ odds of receiving palliative
chemotherapy increased approximately 60% for every unit
increase in the caregiver’s acculturation level (AOR=1.60, 95%
CI 1.20–2.12).
Table 3. Summary of validity analyses for caregiver United States acculturation scale.
Language Cultural Identity Full Scale
Correlation with: Pearson r Pearson r Pearson r
United States birthplace (patient) 0.67 0.67 0.66
Native English speaker (patient) 0.73 0.72 0.71
Interview conducted in English (patient) 0.74 0.73 0.71
Brief Acculturation Scale (patient) 0.65 0.60 0.64
Interview conducted in English (caregiver) 0.78 0.77 0.75
Rater assessment of acculturation (caregiver) 0.88 0.87 0.86
All P-value,0.0001; Missing data: United States birthplace and native English speaker (patient: n=8, 4.7%), interview conducted in English (patient and caregiver: n=9,
5.3%), Brief Acculturation Scale (patient: n=80, 46.6%), and rater assessment of acculturation (caregiver: n=4, 2.3%).
doi:10.1371/journal.pone.0058663.t003
Table 2. Cont.
Full Sample Caregiver USAS
Patient Characteristics
a N (%) Mean (SD) P-value
Parkland 65 (38.0) 2.3 (1.1)
DFCI/MGH 15 (8.8) 4.0 (0.8)
NHOH 17 (10.0) 4.2 (0.7)
Caregiver relationship 0.15
Spouse 85 (49.7) 3.7 (1.3)
Adult child 31 (18.1) 3.5 (1.4)
Other family member or friend 33 (22.1) 3.1 (1.4)
Caregiver identifies as primary
e 154 (96.3) 3.6 0.25
Unpaid, informal care provided by caregiver 0.89
$80% 101 (62.7) 3.6 (1.4)
41–79% 51 (31.1) 3.6 (1.4)
#40 9 (5.5) 3.2 (1.4)
aMissing data: male, age, race/ethnicity, education, health insurance, native English speaker, nativity, and religion (n=8, 4.7%); marriage (n=11, 6.4%), cancer type
(n=10, 5.8%), Karnofsky score (n=11, 6.4%), caregiver relationship (n=22, 12.9%), caregiver identifies as primary caregiver for patient (n=4).
bParticipants were asked whether English was their native language with response options of ‘‘yes’’ or ‘‘no.’’ Study participation mandated English or Spanish fluency,
and interviews were conducted in English or Spanish by trained, bilingual research assistants.
cOther cancers each representing ,5% sample.
dKarnofsky score is a measure of functional status that is predictive of survival, where 0 is dead and 100 is perfect health. The sample median, 70, reflects an ability to
care for self, but not carry on normal activity or work.
eCaregivers were asked: "Do you consider yourself to be the patient’s primary caregiver, defined as a family member or friend who provides the patient with unpaid
assistance with his/her activities of daily living (e.g., bathing, cooking, transportation, housework etc). Caregivers who answered "yes" are included in this category.
doi:10.1371/journal.pone.0058663.t002
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The goal of this study was to develop and validate a measure of
‘‘Americanization’’ that could be used to assess acculturation in
non-US born or first generation American respondents, indepen-
dent of their country of origin. Our results demonstrate that the
United States Acculturation Scale (USAS) is a reliable and valid
measure of ‘‘Americanization’’ in a sample of terminally-ill cancer
patients and their informal caregivers from Mexico, Central and
South America, Europe, and Asia.
In this study, the USAS was closely associated with US-
birthplace, English proficiency, and a trained rater’s evaluation of
the respondent’s degree of Americanization, each of which
provides evidence of the USAS’ criterion validity. Our analyses
also demonstrate the predictive validity of the USAS which was
associated with terminally ill cancer patients’ desire for prognostic
information, end-of-life care preferences, and medical care. In
particular, scores indicating greater acculturation are associated
with increased odds of patients participating in clinical trials and
receiving palliative chemotherapy, compared with scores indicat-
ing lower acculturation levels.
We found that advanced cancer patients’ preferences for
information and specific end-of-life treatments varied by caregiv-
ers’ acculturation level. Specifically, patients with more accultur-
ated caregivers were more likely to want prognostic information,
compared to those with less acculturated caregivers, but were not
more likely to have discussed their end-of-life wishes with a
physician. Previous studies have documented an association
between US acculturation and positive attitudes towards prognos-
tic disclosure within Mexican-American and Japanese cultures.
[43,52,53] Interestingly, we also did not observe any differences in
patients’ comfort asking physicians’ questions about their medical
care by caregivers’ acculturation level. Patients with more
acculturated caregivers were also less likely to want a feeding
tube to extend life or to die in an intensive care unit, compared
with those with less acculturated caregivers. This is not surprising
given that cultural attitudes likely influence how people under-
stand their illness and therefore the medical choices made at the
end-of-life. [54] Our finding that patients with less acculturated
caregivers were more likely to prefer feeding tubes at the end-of-
life may be a reflection of cultural norms, beliefs and values placed
on the provision of food and nutrition by members of many
ethnic/racial minority groups. [36,55].
Other researchers have argued that English language proficien-
cy predicts health care usage more than acculturation. [27] In this
study, language did not explain the effect of acculturation on
Table 5. Associations between Caregiver Acculturation and Patient-Physician Communication and Patients’ Treatment Preferences
(N=171).
Outcome Measure: Full Sample Caregiver USAS Score
Patient Communication and Preferences N % OR (95% CI) AOR (95% CI)
Patient-Physician Communication
Treated with respect
a 162 94.7 –
a –
a –
a –
a
Comfort asking questions about care
b 123 71.9 1.57 (1.21–2.03)*** 1.23 (0.87–1.73)
End-of-life discussion with physician
c 38 22.2 0.82 (0.63–1.06) 0.97 (0.71–1.31)
Treatment Preferences
Prognostic information
d 113 66.1 1.36 (1.06–1.74)** 1.31 (1.00–1.72)*
Life-extending care over comfort
e 47 27.5 1.13 (0.86–1.48) 1.16 (0.85–1.57)
Avoid death in intensive care unit
f 53 31.0 1.36 (1.05–1.76)* 1.36 (1.05–1.76)*
Feeding tube to extend life
g 55 32.2 0.80 (0.64–1.02)
{ 0.68 (0.49–0.99)*
{p#0.10.
*p#0.05.
**p#0.01.
***p#0.001.
Logistic regression models examined associations between acculturation and patient-physician relationships, treatment preferences, terminal illness acceptance, and
advance care planning. Every variable that was associated (p,0.20) with both the predictor and outcome (e.g., age, ethnicity, education, health insurance, native English
language, nativity, cancer type, performance status, religion, institution, survival, and caregiver relationship) was investigated as a potential confounder and retained if
significant at a level of p,0.05. Models adjusted for:
aestimate for measures examining respect and trust in physicians (latter not shown) could not be calculated due to near uniform response (yes),
bForeign born,
cperformance status,
dspousal caregiver,
eperformance status.
fno variables met significance (p#0.05), and
g age.
Missing data: treated with respect, comfort asking questions (n=8, 4.7%); end of life discussion (n=9, 5.3%); prognostic information (n=12, 7.0%); life-extending care
over comfort (n=29, 17.0%); avoid death in intensive care unit (n=14, 8.2%); and feeding tube to extend life (n=13, 7.6%).
doi:10.1371/journal.pone.0058663.t005
Table 4. Associations between rater assessment of caregiver
acculturation and language and cultural identity items.
Rater Assessment of Caregiver Acculturation
Standardized b
Coefficient
a P-value
Language 0.57 ,0.0001
Cultural Identity 0.37 0.0009
aData are expressed as standardized coefficients that reflect the unique
contribution of each predictor (language or cultural identity) on the outcome
(rater’s assessment of caregivers’ acculturation).
doi:10.1371/journal.pone.0058663.t004
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medical care. Language alone does not appear to capture the
broader, more complex cognitive, emotional, and behavioral
components of acculturation. This finding has important implica-
tions for intervention development because it suggests that direct
translations of clinical materials (e.g., chemotherapy consent forms
or educational materials) may be less effective than carefully
crafted documents that address these issues within a larger cultural
context that accounts for patients’ and caregivers’ degree of US
acculturation. It also suggests that that increasing access to patient
navigators who can act as cultural brokers may be a more
promising approach for creating more culturally sensitive cancer
care than would the use of medical interpreters. We believe an
important conclusion of this study is that acculturation as a
construct involves more than simply a recognition of linguistic
differences, and cultural competence requires more than bilin-
guistic proficiency.
Racial and ethnic disparities in clinical trial participation have
been reported previously, [56,57] [7,58,59] but this is the first
study, to our knowledge, to demonstrate that acculturation levels
may influence advanced cancer patients’ enrollment in investiga-
tional trials and receipt of palliative chemotherapy. Several factors
might explain this association. More acculturated patients may
have greater access to institutions offering clinical trials, greater
inherent trust in Western medicine, a higher likelihood of being
referred for trials within institutions due to physicians’ biases,
[60,61] more experience navigating complex health care systems,
and/or fewer logistical barriers (e.g., language difficulties compli-
cating recruitment, travel, childcare responsibilities, inflexible
work-hours). Similarly, less acculturated may have more difficulty
understanding the rationale for non-curative chemotherapy or
obtaining treatment. Future studies should examine the effects of
acculturation on trial participation and use of non-curative
chemotherapy in larger samples within institutions where clinical
trials and patient navigators are readily available to determine the
patient and provider factors that may mediate or moderate the
effect of acculturation on cancer care at the end-of-life.
This study has several limitations. Although the study recruited
participants from six different institutions, the sample size was
small, less acculturated participants were predominantly recruited
from Parkland Hospital, and the study eligibility criteria required
that participants speak Spanish or English, which may limit the
generalizability of our results outside of these populations. In
addition, respondents were asked to self-report a single race/ethnic
status, leaving uncertain the race of respondents who reported
being Hispanic. We also used caregiver proxies to measure
patients’ US acculturation status in order to limit subject burden
because our population of interest consisted of terminally-ill cancer
patients; although indirect, enrolled caregivers were highly
involved in patients’ care (both by patient and caregiver report),
and therefore were likely to be involved in medical decision-
making. In addition, caregivers’ acculturation scores were highly
correlated with patients’ scores on the Cuellar Brief Acculturation
Scale, suggesting that they were reasonable proxies. Finally, the
cross-sectional design of our study does not allow us to evaluate
causality. Future studies should directly examine how the degree of
‘‘Americanization’’ influences patients’ understanding of their
illness, communication with physicians, medical choices, and end-
of-life care in larger, more ethnically diverse samples over time.
Our study describes a new multi-dimensional measure of
acculturation which predicts advanced cancer patients’ end-of-life
preferences, planning, and care. The provision of culturally
sensitive care is likely to become an increasingly important issue
as the Health Care Reform Act extends access to over 30 million
previously uninsured Americans, many of whom will be immi-
grants. Given the associations between acculturation and end-of-
life medical decision-making, our results suggest that health care
providers should be attentive not only to the cultural differences
embedded in racial and ethnic groups, but also to what extent
patients and their families have become ‘‘Americanized.’’
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Table 6. Associations between Caregiver Acculturation and Patient Medical Care (N=171).
Outcome Measure: Full Sample Caregiver USAS Score
Patients’ Medical Care N % OR (95% CI) AOR (95% CI)
Clinical trial
a 22 12.9 2.20 (1.28–3.78)** 2.20 (1.28–3.78)**
Palliative chemotherapy
b 97 56.7 1.39 (1.11–1.75)** 1.59 (1.20–2.12)**
Pain management exclusively
c 53 31.0 0.62 (0.49–0.80)*** 0.75 (0.53–1.07)
**p#0.01.
***p#0.001.
Logistic regression models examined associations between acculturation and patient-physician relationships, treatment preferences, terminal illness acceptance, and
advance care planning. Every variable that was associated (p,0.20) with both the predictor and outcome (e.g., age, ethnicity, education, health insurance, native English
language, nativity, cancer type, performance status, religion, institution, survival, and caregiver relationship) was investigated as a potential confound and retained if
significant at a level of p,0.05. Models adjusted for:
ano variables met significance (p#0.05) criteria for adjustment,
bage and cancer type, and
c spousal caregiver.
Missing data: clinical trial (n=17, 9.9%), palliative chemotherapy (n=14, 8.2%), and pain management (n=16, 9.4%).
doi:10.1371/journal.pone.0058663.t006
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